Abstract
Negative costimulatory molecules, acting through so-called inhibitory pathways, play a cru- cial role in the control of T cell responses. This negative "second signal" opposes T cell receptor activation and leads to downregulation ofT cell proliferation and promotes antigen specific tolerance. Much interest has focused upon these pathways in recent years as a method to control detrimental alloresponses and promote allograft tolerance. However, recent experimental data highlights the complexity of negative costimulatory pathways in alloimmunity. Varying effects are observed from molecules expressed on donor and recip- ient tissues and also depending upon the activation status of immune cells involved.There appears to be significant overlap and redundancy within these systems, rendering this a challenging area to understand and exploit therapeutically. In this article, we will review the literature at the current time regarding the major negative costimulation pathways includ- ing CTLA-4:B7, PD-1:PD-L1/PD-L2 and PD-L1:B7-1, B7-H3, B7-H4, HVEM:BTLA/CD160, and TIM-3:Galectin-9. We aim to outline the role of these pathways in alloimmunity and discuss their potential applications for tolerance induction in transplantation. © 2012 McGrath and Najafian.
Author supplied keywords
Cite
CITATION STYLE
McGrath, M. M., & Najafian, N. (2012). The role of coinhibitory signaling pathways in transplantation and tolerance. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2012.00047
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.